🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Dialysis; Complications

Access Cannulation Trial II NCT05490225NA8 sites📍 Dothan📍 Riverside📍 Boston Voyager Biomedical · Tests: VenaSure SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study NCT06001827NA28 sites📍 Bullhead City📍 Marana📍 Phoenix VenoStent · Tests: SelfWrap Bioabsorbable Perivascular Wrap, Untreated AVF Control Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients NCT06398977NA1 site📍 Chengdu Sichuan Academy of Medical Sciences · Tests: Dapagliflozin A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China NCT06933472Phase 342 sites📍 Granada Hills📍 San Dimas📍 San Dimas Alebund Pharmaceuticals · Tests: AP301, AP301 Low Dose Plasma Biomarkers of Muscle Metabolism During Exercise to the Assessment of Insulin Resistance in CKD Dialysis Patients NCT06360302NA2 sites📍 Montpellier📍 Montpellier University Hospital, Montpellier · Tests: Exercise test, Blood sample, Impedancemetry WISDOM UK: Low Dose-intensity Versus Standard Dose-intensity CRRT in Critically Ill Patients NCT07447791NA1 site📍 London Guy's and St Thomas' NHS Foundation Trust · Tests: low intensity of CRRT, usual intensity of CRRT Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease NCT06249932Phase 42 sites📍 Hsinchu📍 Taipei National Taiwan University Hospital · Tests: Empagliflozin 25 MG, Placebo Clinical Effectiveness and Resource Use in End-Stage Renal Disease Patients: Remote Patient Monitoring Across Dialysis Modalities NCT07781124n/a20 sites📍 Beijing📍 Beijing📍 Beijing Vantive Health LLC · Tests: Remote patient monitoring-automated peritoneal (RPM-APD), Manual peritoneal dialysis (PD) cohort, Maintenance hemodialy… A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation NCT06243731n/a25 sites📍 Anderlecht📍 Leuven📍 Tallinn Takeda · Tests: No Intervention Symptom Monitoring in Hemodialysis NCT05738330NA1 site📍 Waltham University of Pennsylvania · Tests: Symptom Monitoring on Renal Replacement Therapy - Hemodialysis (SMaRRT-HD), Usual Care Quality of Life in Patients Transitioning to Home or In-Center Dialysis (QUALIFY CKD-to-HOME) NCT06458322n/a1 site📍 Montreal Ciusss de L'Est de l'Île de Montréal · Tests: Home dialysis or In-Center dialysis Intraperitoneal Pressure Measurements Survey in Pediatric Centers NCT07339709n/a1 site📍 Strasbourg University Hospital, Strasbourg, France RADIOLOGICAL AND CLINICAL EVALUATION OF RENAL EMBOLIZATION USING EVOH IN DIALYSIS PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A PROSPECTIVE LONGITUDINAL OBSERVATIONAL STUDY NCT07535385n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition. NCT06597201Phase 421 sites📍 Hefei📍 Beijing📍 Wuhan Chengdu Qingshan Likang Pharmaceutical Co., Ltd · Tests: amino acid (15) peritoneal dialysis solution, glucose peritoneal dialysis solution INCremental Dialysis to Improve Health Outcomes in People Starting Haemodialysis (INCH-HD) NCT04932148NA18 sites📍 Concord📍 Frenchs Forest📍 Kogarah The University of Queensland · Tests: Incremental HD, Conventional HD The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations NCT07312981n/a2 sites📍 Herlev📍 Herlev University of Copenhagen The Effect of Gum Arabic (GA) on Residual Renal Function in Adult Dialysis Patients in Abu Dhabi NCT06836206Phase 1, Phase 21 site📍 Abu Dhabi Abu Dhabi Health Services Company · Tests: Gum Arabic, Water Activation of the Contact System and the Immune System in Patients With Chronic Kidney Disease. NCT05266092n/a1 site📍 Odense Odense University Hospital · Tests: Observational study Partners Calciphylaxis Biobank NCT03032835n/a1 site📍 Boston Massachusetts General Hospital CAR-T Cell Therapy for Desensitization in Kidney Transplantation NCT06056102Phase 13 sites📍 Boston📍 New York📍 Philadelphia National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Cyclophosphamide, CART-BCMA, huCART19 Intradialytic Exercise With Blood Flow Restriction in Hemodialysis Patients NCT07269379NA2 sites📍 Strasbourg📍 Villeurbanne University of Avignon · Tests: Chronic phase - HDEX/HDBFRE, Acute phase - HDEX/HDBFRE Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury NCT05758077NA36 sites📍 Birmingham📍 Phoenix📍 Los Angeles SeaStar Medical · Tests: Selective Cytopheretic Device, Standard of Care Investigation of the Validity, Reliability, and Responsiveness of BETY-BQ in Chronic Kidney Disease, on Dialysis, and Kidney Transplantation NCT06591702n/a1 site📍 Ankara Hacettepe University · Tests: Questionnaire study The Microcirculation, Dialysis Modality and Sequestered Salt NCT06327750NA2 sites📍 Amstelveen📍 Amsterdam Amsterdam UMC, location VUmc · Tests: Hemodialysis (DNa = PNa), Hemodialysis (DNa<PNa), Hemodialysis after isolated ultrafiltration (DNa=PNa), High volume… Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community NCT06940414n/a1 site📍 Shanghai Xiujuan Zang · Tests: No Intervention Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System NCT04634916NA17 sites📍 La Jolla📍 San Francisco📍 Jacksonville C. R. Bard · Tests: EndoAVF Creation Continuous Glucose Monitoring in Patients With Diabetes on Peritoneal Dialysis NCT06069518n/a2 sites📍 Mexico City📍 Mexico City Coordinación de Investigación en Salud, Mexico Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access NCT05846581n/a4 sites📍 Bielefeld📍 Leipzig📍 Varese W.L.Gore & Associates · Tests: GORE® ACUSEAL Vascular Graft A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD) NCT07619820Phase 11 site📍 Beijing CSL Behring · Tests: CSL300, Placebo Behavioral AI to Predict and Increase Peritoneal Dialysis Uptake NCT06533254n/a1 site📍 Dallas Scaled Insights · Tests: Predicting choice of dialysis, Behavioral nudges
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy